Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vanhoutte, P.M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vanhoutte, P.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Ageing and endothelial dysfunction

P.M. Vanhoutte*

Institut de Recherches Internationales Servier (IRIS), Courbevoie, France

* Correspondence: Paul M. Vanhoutte, IRIS, 6 place des Pléiades, 92415 Courbevoie Cedex, France.

Abstract

Although the available information is limited, a survey of the literature concerning the effect of ageing on endothelium-dependent responses in animal blood vessels suggests that the release of endothelium-derived relaxing factors (nitric oxide and endothelium-derived hyperpolarizing factor) is reduced, whereas that of endothelium-derived vasoconstrictor prostanoids is augmented. The very few in vitro data on isolated human blood vessels and a number of studies conducted in intact people concur with the animal data. Taken in conjunction, these findings suggest that ageing is accompanied by progressive endothelial dysfunction, which sets the scene for development of atherosclerosis.

Key Words: Atherosclerosis • endothelium-derived contracting factor • endothelium-dependent contractions • endothelium-derived hyperpolarizing factor • endothelium-dependent relaxations • nitric oxide • prostanoids • superoxide anions

References

  1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007–2017[Abstract]
  2. Vanhoutte PM, Houston DS. Platelets, endothelium and vasospasm. Circulation. 1985;72:728–734[Free Full Text]
  3. Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular smooth muscle contraction by the endothelium. Ann Rev Physiol. 1986;48:307–320[CrossRef][Web of Science][Medline]
  4. Vanhoutte PM. The end of a quest? Nature. 1987;327:459–460[CrossRef][Medline]
  5. Vanhoutte PM. The endothelium: modulator of vascular smooth-muscle tone. N Engl J Med. 1988;319:512–513[Web of Science][Medline]
  6. Vanhoutte PM. State of the art lecture: endothelium and control of vascular function. Hypertension. 1989;13:658–667[Abstract/Free Full Text]
  7. Vanhoutte PM. Other endothelium-derived vasoactive factors. Circulation. 1993;87:V9–V17
  8. Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J. 1997;18:E19–E29
  9. Vanhoutte PM. Say NO to ET. J Auton Nerv Syst. 2000;81:271–277[CrossRef][Web of Science][Medline]
  10. Vanhoutte PM. Endothelium-derived free radicals: for worse and for better. J Clin Invest. 2001;107:23–25[Web of Science][Medline]
  11. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor(s) and coronary vasospasm. Circulation. 1989;80:1–9[Abstract/Free Full Text]
  12. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton: CRC Press, Inc; 1990.
  13. Vanhoutte PM, Lüscher TF, Gräser T. Endothelium-dependent contractions. Blood Vessels. 1991;28:74–83[Web of Science][Medline]
  14. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels. 1990;27:238–245[Web of Science][Medline]
  15. Schini VB, Vanhoutte PM. Endothelin-1: a potent vasoactive peptide. Pharmacol Toxicol. 1991;69:1–7[Web of Science][Medline]
  16. Pearson PJ, Vanhoutte PM. Vasodilator and vasoconstrictor substances produced by endothelium. Rev Physiol Biochem Pharmacol. 1993;122:1–67[Medline]
  17. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Respir Cell Mol Biol. 1993;8:1–6
  18. Vanhoutte PM, Shepherd JT. Pharmacology of large coronary arteries. Brandenburg R, Fuster V, Giuliani ER, McGoon DC. Cardiology: Fundamentals and Practice. Chicago: Year Book Medical Publishers; 1990. p. 1159–1171
  19. Vanhoutte PM. Hypercholesterolaemia, atherosclerosis and release of endothelium-derived relaxing factor by aggregating platelets. Eur Heart J. 1991;12:25–32
  20. Vanhoutte PM. Endothelial dysfunction and vascular disease. Panza JA, Cannon RO III. Endothelium, Nitric Oxide and Atherosclerosis. New York: Futura Publishing Co, Inc, Armonk; 1999. p. 79–95
  21. Scott-Burden T, Vanhoutte PM. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation. 1993;87:V51–V55
  22. Shimokawa H, Vanhoutte PM. Endothelium and vascular injury in hypertension and atherosclerosis. Zanchetti A, Mancia G. Handbook of Hypertension, Pathophysiology and Hypertension. Amsterdam: Elsevier; 1997. p. 1007–1068
  23. Vogel RA. Cholesterol lowering and endothelial function. Am J Med. 1999;107:479–487[CrossRef][Web of Science][Medline]
  24. Biegelsen ES, Loscalzo J. Endothelial function and atherosclerosis. Coron Artery Dis. 1999;10:241–256[Web of Science][Medline]
  25. Davidge ST. Prostaglandin H synthase and vascular function. Circ Res. 2001;89:650–660[Abstract/Free Full Text]
  26. Lee TJ-F, Shirasaki Y, Nickols GA. Altered endothelial modulation of vascular tone in aging and hypertension. Blood Vessels. 1987;24:132–136[Web of Science][Medline]
  27. Lücher TF, Dohi Y, Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol. 1992;19(suppl 5):S34–S42
  28. Luscher TF, Tanner FC, Dohi Y. Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation. Pharmacol Toxicol. 1992;70:S32–S39[Web of Science][Medline]
  29. Lüscher TF, Noll G. Endothelium-dependent vasomotion in aging, hypertension, and heart failure. Circulation. 1993;87:V1197–V11103
  30. Dohi Y, Kojima M, Sato K, Lüscher TF. Age-related changes in vascular smooth muscle and endothelium. Drugs Aging. 1995;7:278–291[Web of Science][Medline]
  31. Maria J. Age-related changes in vascular responses: a review. Mech Ageing Dev. 1995;79:71–114[CrossRef][Web of Science][Medline]
  32. Cockcroft JR, Wilkinson IB, Webb DJ. The Trevor Howell Lecture: age, arterial stiffness and the endothelium. Age Ageing. 1997;26(suppl 4):53–60
  33. Maria J, Rodriguez-Martinez MA. Age-related changes in vascular responses. Exp Gerontol. 1999;34:503–512[CrossRef][Web of Science][Medline]
  34. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol. 1999;31:23–37[CrossRef][Web of Science][Medline]
  35. Matz RL, Schott C, Stoclet JC, Andriantsitohaina R. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res. 2000;49:11–18[Web of Science][Medline]
  36. Moritoki H, Hosoki E, Ishida Y. Age-related decrease in endothelium-dependent dilator response to histamine in rat mesenteric artery. Eur J Pharmacol. 1986;126:61–67[CrossRef][Web of Science][Medline]
  37. Hongo K, Nakagomi T, Kassell NF, et al. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke. 1988;19:892–897[Abstract/Free Full Text]
  38. Koga T, Takata Y, Kobayashi K, Takishita S, Yamashita Y, Fujishima M. Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat. Hypertension. 1989;14:542–548[Abstract/Free Full Text]
  39. Dohi Y, Thiel MA, Bühler FR, Lüscher TE. Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension. 1990;15:170–179[Abstract/Free Full Text]
  40. Murohara T, Yasue H, Ohgushi M, Sakaino N, Jougasaki M. Age related attenuation of the endothelium dependent relaxation to noradrenaline in isolated pig coronary arteries. Cardiovasc Res. 1991;25:1002–1009[Abstract/Free Full Text]
  41. Miyata N, Tsuchida K, Okuyama S, Otomo S, Kamata K, Kasuya Y. Age-related changes in endothelium-dependent relaxation in aorta from genetically diabetic WBN/Kob rats. Am J Physiol. 1992;262:H1104–H1109[Web of Science][Medline]
  42. Amerini S, Mantelli L, Filippi S, Ledda E. Effects of aging and hypertension on vasorelaxant activity of calcitonin gene-related peptide: a comparison with other vasodilator agents. J Cardiovasc Pharmacol. 1994;23:432–437[Web of Science][Medline]
  43. Atkinson J, Tatchum-Talom R, Capdeville-Atkinson C. Reduction of endothelial function with age in the mesenteric arterial bed of the normotensive rat. Br J Pharmacol. 1994;111:1184–1188[Web of Science][Medline]
  44. Patemo R, Faraci FM, Heistad DD. Age-related changes in release of endothelium-derived relaxing factor from the carotid artery. Stroke. 1994;25:2459–2462
  45. Atkinson J. Effect of aging and chronic angiotensin I converting enzyme inhibition on the endothelial function of the mesenteric arterial bed of the rat. Am J Cardiol. 1995;76:E19–E23[Medline]
  46. Küng CF, Lüscher TE. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 1995;25:194–200[Abstract/Free Full Text]
  47. Mantelli L, Amerini S, Ledda F. Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol. 1995;25:595–602[Web of Science][Medline]
  48. Muscari C, Giaccari A, Giordano E, Clô C, Guarnieri C, Caldarera CM. Role of reactive oxygen species in cardiovascular aging. Mol Cell Biochem. 1996;160/161:159–166[CrossRef]
  49. Rapoport RM, Williams SP. Role of prostaglandins in acetylcholiae-induced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats. 1996;28:64–75
  50. Arribas SM, Vila E, McGrath JC. Impairment of vasodilator function in basilar arteries from aged rats. Stroke. 1997;28:1812–1820[Abstract/Free Full Text]
  51. Barton M, Cosentino F, Brandes RP, Moreau P, Shaw S, Lüscher TE. Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelia. Hypertension. 1997;30:817–824[Abstract/Free Full Text]
  52. Hashimoto M, Gamoh S, Hossaia S, et al. Age-related changes in aortic sensitivity to noradrenaline and acetylcholine in rats. Clin Exp Pharmacol Physiol. 1998;25:676–681[CrossRef][Web of Science][Medline]
  53. Lönnrot K, Porsti I, Alho H, Wu X, Hervonen A, Tolvanen JP. Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats. Br J Pharmacol. 1998;124:1500–1506[CrossRef][Web of Science][Medline]
  54. Maeso R, Rodrigo E, Munozgarcia R, et al. Factors involved in the effects of Losartan on endothelial dysfunction induced by aging in SHR. Kidney Int. 1998;54:S30–S35[Web of Science]
  55. Maeso R, Rodrigo E, Munozgarcia R, et al. Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats. J Hypertens. 1998;16:665–672[CrossRef][Web of Science][Medline]
  56. Imaoka Y, Osanai T, Kamada T, Mio Y, Satoh K, Okumura K. Nitric oxide-dependent vasodilator mechanism is not impaired by hypertension but is diminished with aging in the rat aorta. J Cardiovasc Pharmacol. 1999;33:756–761[CrossRef][Web of Science][Medline]
  57. Stewart KG, Zhang Y, Davidge ST. Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries. Hypertension. 2000;35:1242–1247[Abstract/Free Full Text]
  58. Van der Zypp A, Kang KB, Majewski H. Age-related involvement of the endothelium in beta-adrenoceptor-mediated relaxation of rat aorta. Eur J Pharmacol. 2000;397:129–138[CrossRef][Web of Science][Medline]
  59. Sullivan JC, Davison CA. Effect of age on electrical field stimulation (EFS)-induced endothelium-dependent vasodilation in male and female rats. Cardiovasc Res. 2001;50:137–144[Abstract/Free Full Text]
  60. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF. Superoxide excess in hypertension and aging. Hypertension. 2001;37:529–534[Abstract/Free Full Text]
  61. Chiaellato A, Pandolfo L, Ragazzi E, et al. Effect of age on rabbit aortic responses to relaxant endothelium-dependent and endothelium-independent agents. Blood Vessels. 1991;28:358–365[Web of Science][Medline]
  62. Hynes MR, Duckles SP. Effect of increasing age on the endothelium-mediated relaxation of rat blood vessels in vitro. J Pharmacol Exper Ther. 1987;241:387–392[Abstract/Free Full Text]
  63. Crespo MJ, Escobales N, Rodriguezsargent C. Endothelial dysfunction in the San Juan hypertensive rat-possible role of the nitric oxide synthase. J Cardiovasc Pharmacol. 1996;27:802–808[CrossRef][Web of Science][Medline]
  64. Giulumian AD, Clark SG, Fuchs LC. Effect of behavioral stress on coronary artery relaxation altered with aging in BHR. Am J Physiol. 1999;276:R435–R440[Web of Science][Medline]
  65. Tschudi MR, Criscione L, Luscher TE. Effect of aging and hypertension on endothelial function of rat coronary arteries. J Hypertens Suppl. 1991;9:S164–S165[Medline]
  66. Tschudi MR, Lüscher TF. Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins. Circulation. 1995;91:2415–2422[Abstract/Free Full Text]
  67. Moreau P, Duscio LV, Luscher TF. Structure and reactivity of small arteries in aging. Cardiovasc Res. 1998;37:247–253[Abstract/Free Full Text]
  68. Schini VB, Vanhoutte PM. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. J Pharmacol Exp Ther. 1992;261:553–559[Abstract/Free Full Text]
  69. Cemadas MR, Demiguel LS, Garcia Duran M, et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res. 1998;83:279–286[Abstract/Free Full Text]
  70. Asai K, Kudej RK, Shen YT, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vase Biol. 2000;20:1493–1499
  71. Asai K, Kudej RK, Takagi G, et al. Paradoxically enhanced endothelin-B receptor-mediated vasoconstriction in conscious old monkeys. Circulation. 2001;103:2382–2386[Abstract/Free Full Text]
  72. Challah M, Nadaud S, Philippe M, et al. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am J Physiol. 1997;42:H1941–H1948
  73. Wiemer G, Linz W, Hatrik S, Scholkens BA, Malinski T. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension. 1997;30:1183–1190[Abstract/Free Full Text]
  74. Klöss S, Bouloumié A, Mülsch A. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension. 2000;35:43–47[Abstract/Free Full Text]
  75. Goettsch W, Lattmann T, Amann K, et al. Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem Biophys Res Commun. 2001;280:908–913[CrossRef][Web of Science][Medline]
  76. Nakashima M, Vanhoutte PM. Age-dependent decrease in endothelium-dependent hyperpolarizations to endothelin-3 in the rat mesenteric artery. J Cardiovasc Pharmacol. 1993;22(suppl 8):S352–S354
  77. Fujii K, Ohmori S, Tominaga M, et al. Age-related changes in endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol. 1993;265:H509–H516
  78. Goto K, Fujii K, Onaka U, Abe I, Fujishima M. Angiotensinconverting enzyme inhibitor prevents age-related endothelial dysfunction. Hypertension. 2000;36:581–587[Abstract/Free Full Text]
  79. Nakajima M, Hashimoto M, Wang F, et al. Aging decreases the production of PGI (2) in rat aortic endothelial cells. Exp Gerontol. 1997;32:685–693[CrossRef][Web of Science][Medline]
  80. Numaguchi Y, Harada M, Osanai H, et al. Altered gene expression of prostacyclin synthase and prosacyclin receptor in the thoracic aorta of spontaneously hypertensive rats. Cardiovasc Res. 1999;41:682–688[Abstract/Free Full Text]
  81. Mombouli JV, Vanhoutte PM. Purinergic endothelium-dependent and -independent contractions in rat aorta. Hypertension. 1993;22:577–583[Abstract/Free Full Text]
  82. Lang MG, Noll G, Lüscher TF. Effect of aging and hypertension on contractility of resistance arteries-modulation by endothelial factors. Am J Physiol. 1985;38:H837–H844
  83. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor(s). Am J Physiol. 1986;250:H822–H827
  84. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344–348[Abstract/Free Full Text]
  85. Shirasaki Y, Su C, Lee TJ-F, et al. Endothelial modulation of vascular relaxation to niuovasodilators in aging and hypertension. J Pharmacol Exper Ther. 1986;239:861–866[Abstract/Free Full Text]
  86. Lüscher TF, Romero JC, Vanhoutte PM. Bioassay of endothelium-derived vasoactive substances in the aorta of normotensive and spontaneously hypertensive rats. J Hypertens Suppl. 1987;4:S81–S83
  87. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension. 1989;13:859–864[Abstract/Free Full Text]
  88. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension. 1992;19:442–445[Abstract/Free Full Text]
  89. Davidge ST, Hubel CA, McLaughlin MK. Impairment of vascular function is associated with an age-related increase of lipid peroxidation in rats. Am J Physiol. 1996;271:R1625–R1631
  90. Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H syn thase-1 and hypersensitivity to prostaglandin Hz in the SHR aorta. Circ Res. 1995;76:1003–1010[Abstract/Free Full Text]
  91. Ge T, Vanhoutte PM, Boulanger CM. Increased response to prostaglandin H2 precedes changes in PGH synthase-1 expression in the SHR aorta. Acta Pharmacol Sin. 1999;20:1087–1092[Web of Science]
  92. Lu M-H, Chao C-F, Chin Y-H, Yu K-R, Pai L. The correlation of blood pressure, age and endothelin-1 binding sites in aortic smooth muscle cells of rats. Circ J. 1998;62:532–536[CrossRef]
  93. Seo B, Lüscher TF. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR-Effects of FR139317 and Bosentan. Hypertension. 1995;25:501–506[Abstract/Free Full Text]
  94. Hatake K, Kakishita E, Wakabayashi I, Sakiyama N, Hishida S. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke. 1990;21:1039–1043[Abstract/Free Full Text]
  95. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 1993;92:2867–2871
  96. Vita JA, Treasure CB, Nabel EG. Coronary vasomotor responses to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491–497[Abstract/Free Full Text]
  97. Yasue H, Matsuyama K, Okumura K, Morikama Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 1990;81:482–490[Abstract/Free Full Text]
  98. Zeiher AM, Drexler H, Sourbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest. 1993;92:652–662
  99. Egashira K, Inou T, Hirooka Y, et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation. 1993;88:77–81[Abstract/Free Full Text]
  100. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–476[Abstract]
  101. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995;91:1981–1987[Abstract/Free Full Text]
  102. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576–582[Abstract/Free Full Text]
  103. Taddei S, Virdis A, Mattei P, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736–743[Abstract/Free Full Text]
  104. Taddei S, Virdis A, Ghiadoni L, et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 2001;38:274–279[Abstract/Free Full Text]
  105. Chauhan A, More RS, Mullins PA, et al. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol. 1996;28:1796–1804[Abstract]
  106. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension. 1996;27:849–853[Abstract/Free Full Text]
  107. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation. 1998;97:1234–1238[Abstract/Free Full Text]
  108. Deng YB, Wang X-F, Le G-R, Zhang Q-P, Lei C-L, Zhang YG. Evaluation of endothelial function in hypertensive elderly patients by high-resolution ultrasonography. Clin Cardiol. 1999;22:705–710[Web of Science][Medline]
  109. Kimura Y, Matsumoto M, Deng Y-B, et al. Impaired endothelial function in hypertensive elderly patients evaluated by high resolution ukrasonography. Can J Cardiol. 1999;15:563–568[Web of Science][Medline]
  110. Sarabi M, Millgard J, Lind L. Effects of age, gender and metabolic factors on endothelium-dependent vasodilation: a population-based study. J Intern Med. 1999;246:265–274[CrossRef][Web of Science][Medline]
  111. Andrawis N, Jones DS, Abernethy DR. Aging is associated with endothelial dysfunction in the human forearm vasculature. J Am Geriatr Soc. 2000;48:193–198[Web of Science][Medline]
  112. Desouza CA, Shapiro LF, Clevenger CM, et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation. 2000;102:1351–1357[Abstract/Free Full Text]
  113. Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension. 1997;30:252–258[Abstract/Free Full Text]
  114. Miyasaki H, Matsuoka H, Cooke JP, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 1999;99:1141–1146[Abstract/Free Full Text]
  115. Flavahan NA, Vanhoutte PM. G-protein and endothelial responses. Blood Vessels. 1990;27:218–229[Web of Science][Medline]
  116. Flavahan N, Vanhoutte PM. Endothelial cell signaling and endothelial dysfunction. Am J Hypertens. 1995;8:28S–41S[CrossRef][Medline]
  117. Boulanger CM, Vanhoutte PM. G-proteins and endotheliumdependent relaxations. J Vase Res. 1997;34:175–185[CrossRef]
  118. Flavahan NA, Shimokawa H, Vanhoutte PM. Inhibition of endothelium-dependent relaxations by phorbol myristate acetate in canine coronary arteries. J Pharmacol Exp Ther. 1991;256:50–55[Abstract/Free Full Text]
  119. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium-removal in porcine coronary arteries. Circ Res. 1989;65:740–753[Abstract/Free Full Text]
  120. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium-removal in porcine coronary arteries. Circ Res. 1989;65:740–753
  121. Miller VM, Flavahan NA, Vanhoutte PM. Pertussis toxin reduces endothelium-dependent and independent responses to alpha2- adrenergic stimulation in systemic canine arteries and veins. J Pharmacol Exp Ther. 1991;257:290–293[Abstract/Free Full Text]
  122. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 1991;261:R1022–R1027
  123. Vasal M, Breitschopf K, Zeiher AM, Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res. 2000;87:540–542[Free Full Text]
  124. Hoffmann J, Haendeler J, Aicher A, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res. 2001;29:709–715
  125. Tokunaga O, Fan J, Watanabe T. Atherosclerosis- and age-related multinucleated variant endothelial cells in primary culture from human aorta. Am J Pathol. 1989;135:967–976[Abstract]
  126. Bilato C, Crow MT. Atherosclerosis and the vascular biology of aging. Aging Clin Exp Res. 1996;8:221–234
  127. Borg-Capra C, Fournet-Bourguignon MP, Janiak P, et al. Morphological heterogeneity with normal expression but altered function of G proteins in cultured regenerated porcine coronary endothelial cells. Br J Pharmacol. 1997;122:999–1008[CrossRef][Web of Science][Medline]
  128. Fournet-Bourguignon MP, Castedo-Delrieu M, Bidouard JP, et al. Phenotopic and functional changes in regenerated porcine coronary endothelial cells. Increased uptake of modified LDL and reduced production of NO. Circ Res. 2000;86:854–861[Abstract/Free Full Text]
  129. Orlandi A, Marcellini M, Spagnoli LG. Aging influences development and progression of early aortic atherosclerosis lesions in cholesterol-fed rabbits. Artherioscler Thromb Vase Biol. 2000;20:1123–1136
  130. Mombouli JV, Nakashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and and hyperpolarization evoked by bradykinin in canine coronary arteries : enhancement by exercise-training. Br J Pharmacol. 1996;117:413–418[Web of Science][Medline]
  131. Vanhoutte PM. Endothelial dysfunction and inhibition of converting enzyme. Eur Heart J. 1998;19:J7–J15
  132. Bult H, Herman AG, Matthys KE. Antiatherosclerosis activity of drugs in relation to nitric oxide function. Eur J Pharmacol. 1999;375:157–176[CrossRef][Web of Science][Medline]
  133. Dart AM, Chin-Dusting JPF. Lipids and the endothelium. Cardiovasc Res. 1999;43:308–322[Abstract/Free Full Text]
  134. Ono H, Ono Y, Frohlich ED. L-arginine reverses severe nephrosclerosis in aged spontaneously hypertensive rats. J Hypertens. 1999;17:121–128[Web of Science][Medline]
  135. Gonzalez Bose LV, Kurnjek ML, Müller A, Terragno NA, Basso N. Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging. J Hypertens. 2001;19:1403–1409[CrossRef][Web of Science][Medline]
  136. Hornig B, Drexler H. Reversal of endothelial dysfunction in humans. Coron Artery Dis. 2001;12:463–473[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
J. D. Maclay, D. A. McAllister, N. L. Mills, F. P. Paterson, C. A. Ludlam, E. M. Drost, D. E. Newby, and W. MacNee
Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., September 15, 2009; 180(6): 513 - 520.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vanhoutte, P.M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vanhoutte, P.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?